Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1488 | 7627 | 39.7 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
346 | 3 | CARDIOTOXICITY//ANTHRACYCLINES//CAMPTOTHECIN | 36072 |
1488 | 2 | CAMPTOTHECIN//TOPOISOMERASE I//SN 38 | 7627 |
1644 | 1 | CAMPTOTHECIN//SN 38//TOPOTECAN | 2558 |
2662 | 1 | TOPOISOMERASE II//DNA TOPOISOMERASE II//TOPOISOMERASE II ALPHA | 2181 |
6168 | 1 | DNA GYRASE//GYRASE//REVERSE GYRASE | 1519 |
7420 | 1 | TOPOISOMERASE I//DNA TOPOISOMERASE I//INDENOISOQUINOLINE | 1369 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CAMPTOTHECIN | authKW | 1024577 | 8% | 44% | 578 |
2 | TOPOISOMERASE I | authKW | 605008 | 4% | 52% | 290 |
3 | SN 38 | authKW | 374932 | 2% | 58% | 162 |
4 | TOPOISOMERASE | authKW | 373084 | 3% | 36% | 261 |
5 | TOPOTECAN | authKW | 369561 | 4% | 33% | 278 |
6 | TOPOISOMERASE II | authKW | 365355 | 3% | 36% | 254 |
7 | DNA TOPOISOMERASE I | authKW | 245051 | 1% | 62% | 99 |
8 | CPT 11 | authKW | 244442 | 2% | 39% | 155 |
9 | IRINOTECAN | authKW | 217104 | 4% | 17% | 328 |
10 | DNA GYRASE | authKW | 214110 | 2% | 44% | 122 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 20035 | 28% | 0% | 2106 |
2 | Biochemistry & Molecular Biology | 11926 | 35% | 0% | 2660 |
3 | Pharmacology & Pharmacy | 5592 | 18% | 0% | 1361 |
4 | Chemistry, Medicinal | 5173 | 8% | 0% | 639 |
5 | Microbiology | 945 | 6% | 0% | 465 |
6 | Cell Biology | 811 | 7% | 0% | 560 |
7 | Biophysics | 779 | 5% | 0% | 364 |
8 | Chemistry, Organic | 567 | 6% | 0% | 427 |
9 | Toxicology | 524 | 3% | 0% | 250 |
10 | Genetics & Heredity | 455 | 5% | 0% | 358 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL PHARMACOL | 47017 | 4% | 4% | 291 |
2 | DANIEL DEN HOED KLIN | 32001 | 0% | 26% | 31 |
3 | ENZYMOL ACIDES NUCL | 27007 | 0% | 75% | 9 |
4 | STEHLIN FDN CANC | 25003 | 0% | 63% | 10 |
5 | DEV THER EUT BRANCH | 24856 | 0% | 22% | 28 |
6 | G MORUZZI BIOCHEM | 20250 | 0% | 56% | 9 |
7 | PURDUE CANC | 17690 | 1% | 10% | 44 |
8 | BIOL PHARMACOL DNA TOPOISOMERASES | 14289 | 0% | 71% | 5 |
9 | MED HEMATOL ONCOL | 13684 | 1% | 5% | 75 |
10 | PEDIAT PHARMACOKINET THER EUT | 12087 | 0% | 17% | 18 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 23307 | 3% | 3% | 208 |
2 | ANTI-CANCER DRUGS | 9137 | 1% | 3% | 87 |
3 | NUCLEIC ACIDS RESEARCH | 8673 | 4% | 1% | 300 |
4 | CANCER RESEARCH | 7858 | 4% | 1% | 284 |
5 | CLINICAL CANCER RESEARCH | 5208 | 2% | 1% | 142 |
6 | JOURNAL OF BIOLOGICAL CHEMISTRY | 4368 | 6% | 0% | 435 |
7 | INVESTIGATIONAL NEW DRUGS | 3830 | 1% | 2% | 50 |
8 | BIOCHEMICAL PHARMACOLOGY | 3334 | 2% | 1% | 128 |
9 | BIOCHEMISTRY | 3250 | 3% | 0% | 219 |
10 | MOLECULAR PHARMACOLOGY | 2681 | 1% | 1% | 83 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CAMPTOTHECIN | 1024577 | 8% | 44% | 578 | Search CAMPTOTHECIN | Search CAMPTOTHECIN |
2 | TOPOISOMERASE I | 605008 | 4% | 52% | 290 | Search TOPOISOMERASE+I | Search TOPOISOMERASE+I |
3 | SN 38 | 374932 | 2% | 58% | 162 | Search SN+38 | Search SN+38 |
4 | TOPOISOMERASE | 373084 | 3% | 36% | 261 | Search TOPOISOMERASE | Search TOPOISOMERASE |
5 | TOPOTECAN | 369561 | 4% | 33% | 278 | Search TOPOTECAN | Search TOPOTECAN |
6 | TOPOISOMERASE II | 365355 | 3% | 36% | 254 | Search TOPOISOMERASE+II | Search TOPOISOMERASE+II |
7 | DNA TOPOISOMERASE I | 245051 | 1% | 62% | 99 | Search DNA+TOPOISOMERASE+I | Search DNA+TOPOISOMERASE+I |
8 | CPT 11 | 244442 | 2% | 39% | 155 | Search CPT+11 | Search CPT+11 |
9 | IRINOTECAN | 217104 | 4% | 17% | 328 | Search IRINOTECAN | Search IRINOTECAN |
10 | DNA GYRASE | 214110 | 2% | 44% | 122 | Search DNA+GYRASE | Search DNA+GYRASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WANG, JC , (1996) DNA TOPOISOMERASES.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 65. ISSUE . P. 635-692 | 401 | 81% | 1741 |
2 | SCHOEFFLER, AJ , BERGER, JM , (2008) DNA TOPOISOMERASES: HARNESSING AND CONSTRAINING ENERGY TO GOVERN CHROMOSOME TOPOLOGY.QUARTERLY REVIEWS OF BIOPHYSICS. VOL. 41. ISSUE 1. P. 41-101 | 214 | 78% | 204 |
3 | CHAMPOUX, JJ , (2001) DNA TOPOISOMERASES: STRUCTURE, FUNCTION, AND MECHANISM.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 70. ISSUE . P. 369-413 | 147 | 80% | 1421 |
4 | FORTUNE, JM , OSHEROFF, N , (2000) TOPOISOMERASE II AS A TARGET FOR ANTICANCER DRUGS: WHEN ENZYMES STOP BEING NICE.PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 64. VOL. 64. ISSUE . P. 221 -253 | 215 | 90% | 229 |
5 | VENDITTO, VJ , SIMANEK, EE , (2010) CANCER THERAPIES UTILIZING THE CAMPTOTHECINS: A REVIEW OF THE IN VIVO LITERATURE.MOLECULAR PHARMACEUTICS. VOL. 7. ISSUE 2. P. 307-349 | 194 | 68% | 108 |
6 | POMMIER, Y , (2013) DRUGGING TOPOISOMERASES: LESSONS AND CHALLENGES.ACS CHEMICAL BIOLOGY. VOL. 8. ISSUE 1. P. 82 -95 | 108 | 79% | 188 |
7 | POMMIER, Y , LEO, E , ZHANG, HL , MARCHAND, C , (2010) DNA TOPOISOMERASES AND THEIR POISONING BY ANTICANCER AND ANTIBACTERIAL DRUGS.CHEMISTRY & BIOLOGY. VOL. 17. ISSUE 5. P. 421-433 | 92 | 88% | 468 |
8 | POMMIER, Y , (2009) DNA TOPOISOMERASE I INHIBITORS: CHEMISTRY, BIOLOGY, AND INTERFACIAL INHIBITION.CHEMICAL REVIEWS. VOL. 109. ISSUE 7. P. 2894-2902 | 116 | 89% | 253 |
9 | CHEN, SH , CHAN, NL , HSIEH, TS , (2013) NEW MECHANISTIC AND FUNCTIONAL INSIGHTS INTO DNA TOPOISOMERASES.ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82. VOL. 82. ISSUE . P. 139 -+ | 169 | 61% | 75 |
10 | BAKSHI, RP , GALANDE, S , MUNIYAPPA, K , (2001) FUNCTIONAL AND REGULATORY CHARACTERISTICS OF EUKARYOTIC TYPE II DNA TOPOISOMERASE.CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY. VOL. 36. ISSUE 1. P. 1 -37 | 220 | 84% | 40 |
Classes with closest relation at Level 2 |